COMP vs NSA

Compass, Inc. exhibits significant fundamental weakness, highlighted by a Piotroski F-Score of 3/9, placing it in the 'Weak' health category. While the company maintains strong top-line revenue growth of 23.10% and a low Price/Sales ratio of 0.84, these are offset by negative profit margins, a negative ROE of -9.79%, and a concerning liquidity position with a current ratio of 0.86. There is a stark disconnect between the bullish analyst target price of $13.25 and the internal reality of consistent earnings misses (0/4 beats in the last year) and aggressive insider selling by the CFO and General Counsel.

NSA presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a severe valuation disconnect. The stock is trading at $42.56, which is nearly 4x its Graham Number ($11.04) and double its Intrinsic Value ($20.35). Most critically, the dividend payout ratio of 330.43% indicates that the current yield is fundamentally unsustainable. While YoY growth metrics are strong, the combination of extreme valuation multiples and dangerously low liquidity (Current Ratio 0.16) outweighs the growth narrative.